Last updated on February 2018

Sonazoid Enhanced Liver Cancer Trial for Early Detection


Brief description of study

The aim of this study is to prove usefulness of contrast-enhanced ultrasound (CE-US) using Sonazoid (TM) in the early detection of HCC as compared with conventional B-mode ultrasound (B-mode US) for hepatitis virus related cirrhosis, who are defined as super high-risk patients for hepatocarcinogenesis,Furthermore, to analyze whether early detection of HCC by CE-US has a survival benefit than that by B-mode US.

Clinical Study Identifier: NCT00822991

Contact Investigators or Research Sites near you

Start Over

Masatoshi Kudo, professor

Kinki University School of Medicine, Department of Gastroenterology and Hepatology
Osaka-Sayama, Japan
1.93miles
  Connect »